Edition:
United States

People: C R Bard Inc (BCR)

BCR on New York Consolidated

319.52USD
18 Sep 2017
Change (% chg)

-- (--)
Prev Close
$319.52
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
597,631
52-wk High
$324.58
52-wk Low
$203.63

Holland, Christopher 

Mr. Christopher S. Holland is Chief Financial Officer, Senior Vice President of the Company. He joined Bard in 2012 as Senior Vice President and Chief Financial Officer. From July 2013 through June 2015, Mr. Holland had responsibility for Bard Medical division. In July 2015, Mr. Holland assumed responsibilities for Business Development, Corporate Marketing, Reimbursement, Healthcare Economics and Strategy. Prior to joining Bard, he held executive positions at ARAMARK Corporation since 2003 and was most recently Senior Vice President, Finance and Treasurer. Previously, Mr. Holland held various positions at J.P. Morgan and Company, Inc., including Vice President, with responsibility for the medical device sector.

Basic Compensation

Total Annual Compensation, USD 629,138
Restricted Stock Awards, USD 1,483,760
Long-Term Incentive Plans, USD --
All Other, USD 1,836,450
Fiscal Year Total, USD 3,949,350

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 7,941 949,034.00
Name Fiscal Year Total

Timothy Ring

12,626,500

John Weiland

7,121,000

James Beasley

4,290,960

Timothy Collins

4,309,940

John Groetelaars

--

Christopher Holland

3,949,350
As Of  30 Dec 2016